Back to results
US 5,945,290 AGranted
Antisense modulation of RhoA expression
AssigneeIsis Pharmaceuticals, Inc.
InventorLex M. Cowsert
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of RhoA. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding RhoA. Methods of using these compounds for modulation of RhoA expression and for treatment of diseases associated with expression of RhoA are provided.
Claims12
An antisense compound 8 to 30 nucleobases in length targeted to a nucleic acid molecule encoding human RhoA, wherein said antisense compound inhibits the expression of human RhoA.
Dependencies are inferred from the claim text.